Skip to main content
. 2020 Jan 15;12(1):92–100. doi: 10.4251/wjgo.v12.i1.92

Table 1.

Baseline characteristics of patients before treatment

Characteristics Before treatment
Sex, M/F 42/4
Age, yr, median (range) 53.5 (36-70)
BCLC stage B/C 1 42/4
Child–Pugh class A/B/C 45/1/0
ECOG performance status 0/12 42/4/0
Laboratory values, median (range)
WBC count, 109/L 4.98 (2.23-10.09)
Platelet count, 109/L 158 (49-371)
Hemoglobin, g/dL 135 (76-159)
Serum AST, IU/L 18.85 (16.20-101.60)
Serum ALT, IU/L 28.7 (9.6-178.8)
Serum total bilirubin, mg/dL 13.2 (5.0-41.4)
Serum albumin, g/dL 38.45 (28.8-45.1)
INR 1.10 (0.92-1.33)
Serum creatinine, mg/dL 65.05 (40.30-106.20)
Serum AFP, ng/mL, baseline < 20 7.86 (1.28-24200.00) (n = 29)
Serum AFP, ng/mL, baseline > 20 170.80 (20.02-24200.00) (n = 17)
Tumor burden and distribution
Unifocal/multifocal 35/11
Unilobar/bilobar 44/2
Lesion diameter (cm)
Largest lesion diameter (mean, range) 14.0 (9.47, 8.2-14.0)
1

Barcelona Clinic Liver Cancer staging system.

2

Eastern Cooperative Oncology Group performance status. BCLC: Barcelona Clinic Liver Cancer; ECOG: Eastern Cooperative Oncology Group; WBC: White blood cell; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; INR: International Normalized Ratio; AFP: α-fetoprotein.